ResearcherUniversity of MiamiNo recent work listed
Shrey Modi
Matched on ORCID iD 0000-0003-4865-1809; OpenAlex author ID A5101984383. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2016: 4 papers · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers · 2022: 2 papers
Papers 8
- Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2022.215591↗
- Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Difference? Co-author DOI 10.1053/j.gastro.2021.12.256↗
- An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. Co-author DOI 10.1007/s11605-020-04681-9↗
- Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer Co-author DOI 10.1053/j.gastro.2021.01.001↗
- Control of Apoptosis in Treatment and Biology of Pancreatic Cancer. Co-author DOI 10.1002/jcb.25284↗
- A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation of New Therapies. Co-author DOI 10.1007/s11605-015-2985-y↗
- Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer. Co-author DOI 10.1007/s11605-015-3000-3↗
- Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer. First author DOI 10.1158/1078-0432.ccr-15-1155↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ashok Kumar Saluja · 8 shared papers, 2016–2022 · strength 0.88
- Paper Old Dog, New Tricks: Use of CA 19-9 for Early Diagnosis of Pancreatic Cancer DOI 10.1053/j.gastro.2021.01.001↗
- Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
- Paper Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Dif… DOI 10.1053/j.gastro.2021.12.256↗
- Vikas Dudeja · 5 shared papers, 2016–2022 · strength 0.45
- Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Surviv… DOI 10.1158/1078-0432.ccr-15-1155↗
- Bhuwan Giri · 4 shared papers, 2016–2022 · strength 0.38
- Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer. DOI 10.1007/s11605-015-3000-3↗
- Sulagna Banerjee · 5 shared papers, 2016–2021 · strength 0.38
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Control of Apoptosis in Treatment and Biology of Pancreatic Cancer. DOI 10.1002/jcb.25284↗
- Paper Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Surviv… DOI 10.1158/1078-0432.ccr-15-1155↗
- Selwyn Maurice Vickers · 2 shared papers, 2022 · strength 0.28
- Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
- Paper Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Dif… DOI 10.1053/j.gastro.2021.12.256↗
- Vineet Kumar Gupta · 2 shared papers, 2022 · strength 0.28
- Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
- Paper Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Dif… DOI 10.1053/j.gastro.2021.12.256↗
- Somnath Pandey · 2 shared papers, 2022 · strength 0.28
- Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
- Paper Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Dif… DOI 10.1053/j.gastro.2021.12.256↗
- Shweta Lavania · 2 shared papers, 2022 · strength 0.28
- Paper Minnelide synergizes with conventional chemotherapy by targeting both cancer and associated stroma components in pancre… DOI 10.1016/j.canlet.2022.215591↗
- Paper Racial Disparity Between Whites and African Americans in Incidence and Outcome of Pancreatic Cancer: Have We Made a Dif… DOI 10.1053/j.gastro.2021.12.256↗
- Vrishketan Sethi · 2 shared papers, 2021–2022 · strength 0.26
- Harrys K.C. Jacob · 2 shared papers, 2021–2022 · strength 0.24
- Sundaram Ramakrishnan · 3 shared papers, 2016–2021 · strength 0.23
- Paper An Immunocompetent Model of Pancreatic Cancer Resection and Recurrence. DOI 10.1007/s11605-020-04681-9↗
- Paper Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Surviv… DOI 10.1158/1078-0432.ccr-15-1155↗
- Paper A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation… DOI 10.1007/s11605-015-2985-y↗
- Nikita Sharma · 1 shared paper, 2022 · strength 0.15
- Ashley Nicole Middleton · 1 shared paper, 2022 · strength 0.13
- Haleh Amirian · 1 shared paper, 2022 · strength 0.13
- Kaustav Majumder · 2 shared papers, 2016 · strength 0.12
- Paper Minnelide Overcomes Oxaliplatin Resistance by Downregulating the DNA Repair Pathway in Pancreatic Cancer. DOI 10.1007/s11605-015-3000-3↗
- Paper A Novel Immunocompetent Mouse Model of Pancreatic Cancer with Robust Stroma: a Valuable Tool for Preclinical Evaluation… DOI 10.1007/s11605-015-2985-y↗
- Tejeshwar Jain · 1 shared paper, 2021 · strength 0.11
- Anthony R. Ferrantella · 1 shared paper, 2021 · strength 0.11
- Prateek Sharma · 1 shared paper, 2021 · strength 0.11
- Nipun B. Merchant · 1 shared paper, 2021 · strength 0.11
- Xianda Zhao · 1 shared paper, 2016 · strength 0.07
- Olivia McGinn · 1 shared paper, 2016 · strength 0.07
- Rohit Chugh · 1 shared paper, 2016 · strength 0.05
- Alice Nomura · 1 shared paper, 2016 · strength 0.05
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.